ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 114 filers reported holding ESPERION THERAPEUTICS INC NE in Q4 2015. The put-call ratio across all filers is 1.12 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $361,000 | +30.3% | 5,000 | +19.0% | 0.11% | +29.4% |
| Q4 2017 | $277,000 | -81.9% | 4,200 | -86.3% | 0.08% | -76.5% |
| Q3 2017 | $1,533,000 | -64.8% | 30,600 | -67.5% | 0.36% | -63.7% |
| Q2 2017 | $4,356,000 | -65.6% | 94,118 | -73.7% | 0.99% | +29.4% |
| Q1 2017 | $12,658,000 | +20996.7% | 358,493 | +7316.1% | 0.77% | +38300.0% |
| Q4 2016 | $60,000 | +172.7% | 4,834 | +202.1% | 0.00% | +100.0% |
| Q3 2016 | $22,000 | +633.3% | 1,600 | +433.3% | 0.00% | – |
| Q2 2016 | $3,000 | -97.9% | 300 | -96.4% | 0.00% | -100.0% |
| Q1 2016 | $141,000 | +182.0% | 8,300 | +267.1% | 0.01% | +266.7% |
| Q4 2015 | $50,000 | +316.7% | 2,261 | +352.2% | 0.00% | +200.0% |
| Q3 2015 | $12,000 | – | 500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 3,791,300 | $3,715,474 | 4.82% |
| Two Seas Capital LP | 7,672,170 | $7,518,727 | 1.51% |
| Parkman Healthcare Partners LLC | 1,997,071 | $1,957,130 | 0.36% |
| Monaco Asset Management SAM | 1,171,779 | $1,148,343 | 0.34% |
| TANG CAPITAL MANAGEMENT LLC | 1,850,000 | $1,813,000 | 0.26% |
| Ikarian Capital, LLC | 1,737,636 | $1,702,883 | 0.20% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 3,189,517 | $3,125,727 | 0.12% |
| GSA CAPITAL PARTNERS LLP | 1,116,655 | $1,094 | 0.09% |
| XTX Topco Ltd | 519,129 | $508,746 | 0.09% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 60,000 | $58,800 | 0.08% |